- Service Name
RetinaRisk
- Industry
Healthcare, HealthTech, Medical Technology, Diabetic Eye Care
- Main Value Proposition
RetinaRisk empowers patients and healthcare providers with tools to prevent vision loss from diabetes through early detection and personalized risk management.
- Description
RetinaRisk is a HealthTech service that provides innovative solutions for diabetic eye care through a mobile app, web-based clinical decision support, and an API. It aims to prevent vision loss from diabetes by enabling early detection and personalized risk assessment.
- Key Features
Web-based clinical decision support service (iClinic); Personalized risk calculation via mobile app; API for system-to-system integration with healthcare providers; Extensive clinical validation of the RetinaRisk algorithm
- Use Cases
RetinaRisk is most valuable in scenarios such as routine diabetic eye screenings, patient education on risk factors, and integration into healthcare systems for improved patient management.
- Competitive advantages
Improves screening capacity by up to 60%; Offers personalized risk assessments for patients; Facilitates integration with existing healthcare systems through its API
- Strengths
The service is backed by extensive clinical research, offers a user-friendly interface for both patients and healthcare providers, and has demonstrated effectiveness in improving patient outcomes.
- Positioning
RetinaRisk positions itself as a leader in diabetic eye care technology, focusing on prevention and personalized healthcare solutions.
- Audience
The target users include healthcare providers (ophthalmologists, endocrinologists), patients with diabetes, diabetes care organizations, and health insurers.
- CTA
Learn More About the iClinic, Learn More About our App, Learn More About our API
- Tags
Diabetic Retinopathy
HealthTech
Early Detection
Personalized Care
- Tagline
We Are Revolutionizing Diabetic Eye Care
- Tone of Voice
Professional, informative, supportive
- Differentiation
RetinaRisk stands out in the market due to its clinically validated algorithm developed by leading experts, which provides a comprehensive approach to diabetic eye care.
- Brand Positioning
The brand is identified as innovative and patient-centric, emphasizing its commitment to transforming diabetic eye care through technology.
- Founded
2008-01-01
- Founders
Arna Gudmundsdottir
Einar Stefansson
Thor Aspelund